| KVUE |
Report |
Adjusted diluted EPS |
IN-LINE |
pred ~$0.310 vs. cons $0.313 |
LOW |
| KVUE |
Report |
Net sales |
IN-LINE |
pred ~$3.950B vs. cons $3.964B |
LOW |
| KVUE |
Report |
Organic sales growth |
MISS |
pred ~+1.8% vs. cons +2.47% |
LOW |
| KVUE |
Guide |
FY26 / 2H26 operating outlook |
UNCHANGED |
no formal guidance vs. cons UNVERIFIED |
LOW |
| KVUE |
Guide |
KMB transaction timing (2H26) |
UNCHANGED |
reiterate 2H26 expected closing vs. cons UNVERIFIED |
LOW |
| KVUE |
Return |
Day-1 residual (stock − beta × S&P 500) |
-0.5% |
— |
LOW |
| KVUE |
Return |
5-day cumulative residual |
-1.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — organic miss with no forward offset |
LOW |